Emtricitabine, nelfinavir, and tenofovir and Guselkumab Subcutaneous
Determining the interaction of Emtricitabine, nelfinavir, and tenofovir and Guselkumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: guselkumab
Brand name: Tremfya, Tremfya One-Press
Synonyms: Guselkumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine, nelfinavir, and tenofovir-GVOKE
- Emtricitabine, nelfinavir, and tenofovir-Gvoke HypoPen injection
- Emtricitabine, nelfinavir, and tenofovir-Gvoke Injection
- Emtricitabine, nelfinavir, and tenofovir-Gvoke PFS injection
- Emtricitabine, nelfinavir, and tenofovir-Gynecort Maximum Strength
- Emtricitabine, nelfinavir, and tenofovir-Gynodiol
- Guselkumab Subcutaneous-Emtricitabine, rilpivirine, and tenofovir
- Guselkumab Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Guselkumab Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Guselkumab Subcutaneous-Emtriva
- Guselkumab Subcutaneous-Emtriva (Emtricitabine Capsules)
- Guselkumab Subcutaneous-Emtriva (Emtricitabine Solution)